Xencor to Present at the 2021 Cantor Virtual Global Healthcare Conference Read more about Xencor to Present at the 2021 Cantor Virtual Global Healthcare Conference
Xencor Reports Second Quarter 2021 Financial Results Read more about Xencor Reports Second Quarter 2021 Financial Results
Xencor to Present at Upcoming Investor Conferences Read more about Xencor to Present at Upcoming Investor Conferences
Xencor to Host Second Quarter 2021 Financial Results Webcast and Conference Call on August 4, 2021 Read more about Xencor to Host Second Quarter 2021 Financial Results Webcast and Conference Call on August 4, 2021
Xencor to Present at the Jefferies Virtual Healthcare Conference Read more about Xencor to Present at the Jefferies Virtual Healthcare Conference
Sotrovimab (VIR-7831), an Investigational Antibody Utilizing Xencor's Xtend™ Technology, Receives U.S. FDA Emergency Use Authorization for the Treatment of COVID-19 Read more about Sotrovimab (VIR-7831), an Investigational Antibody Utilizing Xencor's Xtend™ Technology, Receives U.S. FDA Emergency Use Authorization for the Treatment of COVID-19
Xencor and Bristol Myers Squibb Enter License Agreement for Use of Xtend™ XmAb® Technology in SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19 Read more about Xencor and Bristol Myers Squibb Enter License Agreement for Use of Xtend™ XmAb® Technology in SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19
Xencor to Present at the 2021 RBC Capital Markets Global Healthcare Virtual Conference Read more about Xencor to Present at the 2021 RBC Capital Markets Global Healthcare Virtual Conference
Xencor Reports First Quarter 2021 Financial Results Read more about Xencor Reports First Quarter 2021 Financial Results
Xencor Doses First Subject in Phase 1 Study of XmAb®564, an Engineered IL-2 Cytokine in Development for Autoimmune Diseases Read more about Xencor Doses First Subject in Phase 1 Study of XmAb®564, an Engineered IL-2 Cytokine in Development for Autoimmune Diseases
